Published: Oct 12, 2023
Updated: Mar 06, 2026

Multiple sclerosis (MS) is a brain and spinal cord condition that can be devastating (central nervous system). The protective sheath (myelin) that surrounds nerve fibres is attacked by the immune system in MS, causing communication issues between the brain and the rest of the body. The condition might eventually cause permanent nerve injury or degeneration. Some MS facts:
The amount of nerve damage and which nerves are damaged determine the signs and symptoms of MS. Some persons with severe MS lose their ability to walk independently or at all, while others go into remission for long periods of time without experiencing any new symptoms. Since then, multiple sclerosis has remained incurable. Stem cell therapy, on the other hand, can assist in speedy recovery from attacks, change the course of the disease, and manage symptoms without causing any further complications. Stem cell has emerged as a new breakthrough for Multiple sclerosis in 2022. Patients with Multiple Sclerosis may benefit from stem cell therapy. Mesenchymal stem cells can lower inflammation and modify the immune system, which could be tremendously advantageous for MS sufferers. To know more about it, continue reading⦠Symptoms and Causes of Multiple Sclerosis (MS)Symptoms
Causes
Clinically isolated syndrome (CIS)- A pre-MS disease characterised by a single bout of symptoms lasting at least 24 hours is known as CIS. Demyelination of the CNS is the cause of these symptoms. Although this experience is typical of MS, it isn't enough to diagnose the disease. You're more likely to be diagnosed with RRMS if you have more than one lesion or a positive oligoclonal band (OCB) in your spinal fluid during a spinal tap. You're less likely to be diagnosed with MS if these lesions aren't present or if your spinal fluid doesn't reveal OCBs. Relapsing-remitting MS (RRMS)- Clear relapses of disease activity are followed by remissions in relapsing-remitting MS (RRMS). Symptoms are minor or nonexistent during remission periods, and disease progression is modest to moderate. According to the National Multiple Sclerosis Society, RRMS is the most frequent form of MS at the time of start, accounting for around 85 %. Primary-progressive MS (PPMS)- If you have primary progressive MS (PPMS), your neurological function will deteriorate over time as your symptoms worsen. Short periods of stability can, however, occur. When there are new or enhancing brain lesions, the terms "active" and "not active" are occasionally employed to indicate disease activity. PPMS affects about 15% of patients with MS. Secondary-progressive MS (SPMS)- Secondary-progressive multiple sclerosis (SPMS) is a form of multiple sclerosis. After relapsing-remitting MS, it's considered the following stage (RRMS). There are no longer any evidence of remission in SPMS. This indicates that despite treatment, the illness is deteriorating.
The importance of Stem Cell Therapy for Multiple Sclerosis is a silent & chronic disease, which affects younger adults, often women. MS can be difficult to diagnose and its symptoms could vary person to person. Issues with the traditional treatment methods- Unfortunately, a cure doesnât exist yet for multiple sclerosis (MS). Current MS treatment procedures try to relieve symptoms but do not address the underlying problems. Worse, many of the medications used to treat MS symptoms have negative side effects and are unable to prevent disease progression in many patients. Finally, the costs of these treatments often put a strain on the patient's finances. For example, an annual regimen of Ocrevus (ocrelizumab), a newer medicine, can cost upwards of $65,000 USD. Stem cell treatment for MS- A person with MS has a variety of treatment choices, including stem cell therapy. Stem cells are cells that have the ability to convert into different cell types. They can also renew, producing an endless supply of new cells. This makes them beneficial in the treatment of MS. The healing and repair-promoting characteristics of stem cell therapy for MS have been proven. The use of umbilical cord cells produced from enlarged cord tissue has the potential to improve MS treatment. MSCs (mesenchymal stem cells) can help the body fight inflammation. Stem cells will help to regulate the immune system and prevent future myelin breakdown once they have been delivered. This makes mesenchymal stem cells (MSCs) a promising treatment option for MS and other diseases marked by inflammation and/or tissue damage.
While there is no cure for MS, stem cell therapy can reduce patients' symptoms and decrease the disease's development. As a result, there are no eligibility requirements unless the patient has Multiple Sclerosis (any of the conditions). Other factors on the basis of Multiple sclerosis condition are evaluated-
Stem Cell Treatment Protocol used for COPD by GAIA (in association with CEMAB) Although there is no cure for MS, there are treatments that help delay the disease's course, lessen the number and severity of relapses, and alleviate symptoms. Scientists and doctors are increasingly looking into using stem cell treatment to regenerate various bodily cells and restore function to patients who have lost it due to medical reasons. CEMAB (in partnership with GAIA) has developed treatment protocols for every condition that can be treated with stem cell therapy. The MS protocol tries to lower the body's overall levels of chronic low-grade inflammation. The consequences are expected to linger for a long period. Treatment Protocol-
Researchers hope that one day, stem cell therapy techniques may be able to reverse the damage done by MS and restore functionality in the nervous system.
Multiple sclerosis (MS) is a neurological and autoimmune disease in which the body's immune system turns against itself. Stem cell therapy, specifically utilising mesenchymal stem cells (MSCs), has shown considerable promise in the treatment of the disease. Since stem cell therapy can be both immunomodulatory (meaning it can control the immune system) and regenerative, it's a promising treatment option for MS and other diseases marked by inflammation and tissue degeneration. Transplantation with mesenchymal stem cells (MSCs) has also been demonstrated to reduce the course of MS in patients. MS Patients may be able to expect an increase in energy, flexibility, strength, mobility, and control of basic function. MS-specific advantages you can avail with stem cell therapy are-
Other benefits of Stem cell treatment for COPD, especially from GAIA (in association with CEMAB) via MediGence-
Applying for stem cell therapy is very convenient and hassle-free for you through MediGence-

Amit Bansal is an entrepreneur, Co-Founder, and CEO of MediGence. He has more than 17 years of strong technology experience. Having worked for some of the recognised companies in India, Australia, and travelled worldwide to help businesses grow multi-fold under his leadership and strategic guidance.

Dr. Vishwas Kaushik, an accomplished Belgorod State University graduate with an MBBS, is known for his impactful contributions to healthcare. Driven by a passion for global well-being, he seamlessly led domestic operations at VMV Group of Companies and orchestrated success at Clear Medi Cancer Centre. His adept team management and operational skills have positioned him as a luminary in healthcare tourism, shaping a future where compassionate, world-class medical care knows no boundaries.





Delhi, India

Istanbul, Turkey

Istanbul, Turkey

Istanbul, Turkey